Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes.
- DOI
- 10.1002/acn3.51639
- Published
- 2022 Sep
- Container
- Annals of clinical and translational neurology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/acn3.51639,
title = {Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes.},
author = {Afshinnia F and Reynolds EL and Rajendiran TM and Soni T and Byun J and Savelieff MG and Looker HC and Nelson RG and Michailidis G and Callaghan BC and Pennathur S and Feldman EL},
year = {2022},
journal = {Annals of clinical and translational neurology},
doi = {10.1002/acn3.51639},
url = {https://doi.org/10.1002/acn3.51639}
}RIS
TY - JOUR TI - Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes. AU - Afshinnia F AU - Reynolds EL AU - Rajendiran TM AU - Soni T AU - Byun J AU - Savelieff MG AU - Looker HC AU - Nelson RG AU - Michailidis G AU - Callaghan BC AU - Pennathur S AU - Feldman EL PY - 2022 JO - Annals of clinical and translational neurology DO - 10.1002/acn3.51639 UR - https://doi.org/10.1002/acn3.51639 ER -
APA
F, A., EL, R., TM, R., T, S., J, B., MG, S., HC, L., RG, N., G, M., BC, C., S, P., & EL, F. (2022). Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes.. Annals of clinical and translational neurology. https://doi.org/10.1002/acn3.51639
Source records
- pubmed · retrieved 2026-09-26T12:25:48.802Z